References
- Tuffnell DJ. United Kingdom amniotic fluid embolism register. BJOG. 2005; 112: 1625–9
- Moore J, Baldisseri MR. Amniotic fluid embolism. Crit Care Med. 2005; 33: S279–85
- Kane SK. Historical perspective of amniotic fluid embolism. Int Anesthesiol Clin. 2005; 43: 99–108
- Turillazzi E, Gambassi R, Gherardi M, Fineschi V. The diagnosis of amniotic-fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase. Int J Legal Med. 1998; 111: 238–43
- Kramer MS, Rouleau J, Baskett TF, Joseph KS. Maternal Health Study Group of the Canadian Perinatal Surveillance System. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet. 2006; 368: 1444–8
- Moore J. Amniotic fluid embolism: on the trail of an elusive diagnosis. Lancet. 2006; 368: 1399–401
- Stafford I, Sheffield J. Amniotic fluid embolism. Obstet Gynecol Clin North Am. 2007; 34: 545–53
- Wagner M. From caution to certainty: hazards in the formation of evidence-based practice – a case study on evidence for an association between the use of uterine stimulant drugs and amniotic fluid embolism. Paediatr Perinat Epidemiol. 2005; 19: 173–6
- Pallasmaa N, Ekblad U, Gissler M. Severe maternal morbidity and the mode of delivery. Acta Obstet Gynecol Scand. 2008; 87: 662–8
- Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol. 2008; 199: 49 e1–8
- Samuelsson E, Hellgren M, Högberg U. Pregnancy-related deaths due to pulmonary embolism in Sweden. Acta Obstet Gynecol Scand. 2007; 86: 435–43
- Fineschi V, Riezzo I, Cantatore S, Pomara C, Turillazzi E, Neri M. Complement C3a expression and tryptase degranulation as promising histopathological tests for diagnosing fatal amniotic fluid embolism. Virchows Arch. 2009; 454: 283–90